Faron Pharmaceuticals Oy (LSE:FARN) - Share price - Overview


Stock Report

Faron Pharmaceuticals Oy FARN

Last Price
GBX60.00

Day Change
-2.00|-3.23%

As of 21/03/2019
16:34:22 GMT | GBX
Minimum 15 Minutes Delay.

Last Close62.00p
Day Range60.00 - 65.00
Mkt Cap19.24Mil
52-Wk Range50.05 - 865.00
Yield %-
ISINFI4000153309
Volume64,349
P/E-82.42
P/SInfinity
P/CF-0.91

Share Price

Total Returns 20/03/2019

 Chg (%)  
More ...
Faron Pharmaceuticals Oy6.90 
FTSE 100 TR GBP1.58
 
Financials
201520162017
More ...
Income Statement
Turnover0.520.950.00
Operating Profit-5.84-9.70-19.77
Net Profit-6.19-10.14-21.06
Reported EPS-0.30-0.42-0.76
Balance Sheet
Current Assets13.7913.9513.23
Non Current Assets1.031.801.66
Total Assets14.8215.7514.89
Current Liabilities2.204.658.06
Total Liabilities---
Total Equity11.188.404.74
Cash Flow
Operating Cash Flow-7.10-9.34-18.36
Net Change in Cash10.83-0.22-1.88
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
21/06/2018PurchaseDr. Markku Tapani Jalkanen71.0012,0008,520.00
21/06/2018PurchaseDr. Markku Tapani Jalkanen71.0024,00017,040.00
20/06/2018PurchaseDr. Frank Murdoch Armstrong75.0013,3009,975.00
20/06/2018PurchaseMr. Yrjo Erik Kristian Wichmann67.005,2003,484.00

Company Profile

Faron Pharmaceuticals Oy is a clinical stage biopharmaceutical company developing novel treatments for medicalconditions. The company currently has a pipeline focusing on acute organ traumas,vascular damage and cancer immunotherapy.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 08/05/2019

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-307.20
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive Director, Vice ChairmanMr. Matti Esa Manner
Executive Director, Chief Executive OfficerDr. Markku Tapani Jalkanen
Executive Director, Chief Financial OfficerMr. Yrjo Erik Kristian Wichmann
Non-Executive Director, ChairmanDr. Frank Murdoch Armstrong
Non-Executive DirectorMr. Leopoldo Giampaolo Zambeletti
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.